Addition of glomerular lesion severity improves the value of anemia status for the prediction of renal outcomes in Chinese patients with type 2 diabetes

References

• Thomas S, Rampersad M. Anaemia in diabetes. Acta Diabetol. 2004;41(Suppl 1):S13–S7.
   PubMedGoogle Scholar
• Li Y, Shi H, Wang W-M, et al. Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross-sectional study. Medicine. 2016;95(24):e3872.
   PubMed Web of Science ®Google Scholar
• Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLOS One. 2014;9(1):e84943.
   PubMed Web of Science ®Google Scholar
• Hörl WH. Anaemia management and mortality risk in chronic kidney disease. Nat Rev Nephrol. 2013;9(5):291–301.
   PubMed Web of Science ®Google Scholar
• Zoppini G, Targher G, Chonchol M, et al. Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. Atherosclerosis. 2010;210(2):575–580.
   PubMed Web of Science ®Google Scholar
• Gruber M, Hu C-J, Johnson RS, et al. Acute postnatal ablation of hif-2alpha results in anemia. Proc Natl Acad Sci USA. 2007;104(7):2301–2306.
   PubMed Web of Science ®Google Scholar
• Yoon D, Pastore YD, Divoky V, et al. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem. 2006;281(35):25703–25711.
   PubMed Web of Science ®Google Scholar
• Simonson TS, Yang Y, Huff CD, et al. Genetic evidence for high-altitude adaptation in Tibet. Science. 2010;329(5987):72–75.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang X, Wang T, et al. Associations between high-altitude residence and end-stage kidney disease in Chinese patients with type 2 diabetes. High Alt Med Biol. 2020;21(4):396–405.
   PubMed Web of Science ®Google Scholar
• Sagar SK, Zhang C, Guo Q, et al. Role of expression of endothelin-1 and angiotensin-II and hypoxia-inducible factor-1α in the kidney tissues of patients with diabetic nephropathy. Saudi J Kidney Dis Transpl. 2013;24:959–964.
   PubMedGoogle Scholar
• Wang Z, Tang L, Zhu Q, et al. Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int. 2011;79(3):300–310.
   PubMed Web of Science ®Google Scholar
• Pinsker JE, Shank T, Dassau E, et al. Comment on American Diabetes Association. Approaches to glycemic treatment. Sec. 7. In standards of medical care in diabetes-2015. Diabetes Care 2015;38(Suppl. 1):S41-S48. Diabetes Care. 2015;38(10):e174–S48.
   PubMed Web of Science ®Google Scholar
• An Y, Xu F, Le W, et al. Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrol Dial Transplant. 2015;30(2):257–266.
   PubMed Web of Science ®Google Scholar
• Tervaert TW, Mooyaart AL, Amann K, et al. Renal pathology S. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556–563.
   PubMed Web of Science ®Google Scholar
• Mise K, Yamaguchi Y, Hoshino J, et al. Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. PLOS One. 2017;12(8):e0183190.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zou Y, Zhang J, et al. Serum transferrin predicts end-stage renal disease in type 2 diabetes mellitus patients. Int J Med Sci. 2020;17(14):2113–2124.
   PubMed Web of Science ®Google Scholar
• Centers For Disease C. CDC criteria for anemia in children and childbearing-aged women. MMWR Morb Mortal Wkly Rep. 1989;38:400–404.
   PubMedGoogle Scholar
• WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and mineral nutrition information system. Geneva: World Health Organization; 2011.
   Google Scholar
• Zhao L, Li L, Ren H, et al. Association between serum alkaline phosphatase and renal outcome in patients with type 2 diabetes mellitus. Ren Fail. 2020;42(1):818–828.
   PubMed Web of Science ®Google Scholar
• Zhao L, Ren H, Zhang J, et al. Diabetic retinopathy, classified using the lesion-aware deep learning system, predicts diabetic end-stage renal disease in Chinese patients. Endocr Pract. 2020;26(4):429–443.
   PubMed Web of Science ®Google Scholar
• Zhao LJ, Xiao Y, Meng X, et al. Application of a simple quantitative assessment of atherosclerotic lesions in freshly isolated aortas from rabbits. Cardiovasc Toxicol. 2018;18(6):537–546.
   PubMed Web of Science ®Google Scholar
• Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509.
   Web of Science ®Google Scholar
• Zhang J, Zhang R, Wang Y, et al. The level of serum albumin is associated with renal prognosis in patients with diabetic nephropathy. J Diabetes Res. 2019;2019:1–9.
   Web of Science ®Google Scholar
• Lee MY, Huang JC, Chen SC, et al. Association of HbA1C variability and renal progression in patients with type 2 diabetes with chronic kidney disease stages 3(-)4. Int J Mol Sci. 2018;19(12):4116.
   Web of Science ®Google Scholar
• Yamanouchi M, Hoshino J, Ubara Y, et al. Clinicopathological predictors for progression of chronic kidney disease in nephrosclerosis: a biopsy-based cohort study. Nephrol Dial Transplant. 2018;34(7):1182–1188.
   Web of Science ®Google Scholar
• Mise K, Hoshino J, Ueno T, et al. Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy. Diabet Med. 2015;32(4):546–555.
   PubMed Web of Science ®Google Scholar
• He BB, Xu M, Wei L, et al. Relationship between anemia and chronic complications in Chinese Patients with type 2 diabetes mellitus. Arch Iranian Med. 2015;18:277–283.
   PubMed Web of Science ®Google Scholar
• Fufaa GD, Weil EJ, Lemley KV, et al. Structural predictors of loss of renal function in American Indians with type 2 diabetes. CJASN. 2016;11(2):254–261.
   PubMed Web of Science ®Google Scholar
• Najafian B, Fogo AB, Lusco MA, et al. AJKD atlas of renal pathology: diabetic nephropathy. Am J Kidney Dis. 2015;66(5):e37–e38.
   PubMed Web of Science ®Google Scholar
• Babazono T, Hanai K, Suzuki K, et al. Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria. Diabetologia. 2006;49(6):1387–1393.
   PubMed Web of Science ®Google Scholar
• Matoba K, Kawanami D, Okada R, et al. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α. Kidney Int. 2013;84(3):545–554.
   PubMed Web of Science ®Google Scholar
• Kong KH, Oh HJ, Lim BJ, et al. Selective tubular activation of hypoxia-inducible factor-2α has dual effects on renal fibrosis. Sci Rep. 2017;7(1):11351.
   PubMedGoogle Scholar
• Baumann B, Hayashida T, Liang X, et al. Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3. Kidney Int. 2016;90(4):797–808.
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Ferguson DJ, Nicholls LG, et al. The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int. 1997;52(3):715–724.
   PubMed Web of Science ®Google Scholar
• Lee Y-T, Chiu H-C, Su H-M, et al. Lower hemoglobin concentrations and subsequent decline in kidney function in an apparently healthy population aged 60 year and older. Clinica Chimica Acta; Int J Clin Chem. 2008;389(1–2):25–30.
   PubMed Web of Science ®Google Scholar
• Keane WF, Lyle PA. Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study. Am J Kidney Dis. 2003;41(3):S22–S5.
   PubMed Web of Science ®Google Scholar
• Rossing K, Christensen PK, Hovind P, et al. Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004;66(4):1596–1605.
   PubMed Web of Science ®Google Scholar
• Loutradis C, Skodra A, Georgianos P, et al. Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: a nested case-control study. WJN. 2016;5(4):358–366.
   Google Scholar
• Thomas MC, MacIsaac RJ, Tsalamandris C, et al. Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care. 2003;26(4):1164–1169.
   PubMed Web of Science ®Google Scholar
• Bosman DR, Winkler AS, Marsden JT, et al. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care. 2001;24(3):495–499.
   PubMed Web of Science ®Google Scholar
• Thomas M, Tsalamandris C, MacIsaac R, et al. Anaemia in diabetes: an emerging complication of microvascular disease. Curr Diabetes Rev. 2005;1(1):107–126.
   PubMedGoogle Scholar
• Nordquist L, Friederich-Persson M, Fasching A, et al. Activation of hypoxia-inducible factors prevents diabetic nephropathy. J Am Soc Nephrol. 2015;26(2):328–338.
   PubMed Web of Science ®Google Scholar
• Chen N, Hao C, Peng X, et al. Roxadustat for anemia in patients with kidney disease not receiving dialysis. N Engl J Med. 2019;381(11):1001–1010.
   PubMed Web of Science ®Google Scholar
• Mehdi U, Toto RD. Anemia, diabetes, and chronic kidney disease. Diabetes Care. 2009;32(7):1320–1326.
   PubMed Web of Science ®Google Scholar
• Chapter 1: diagnosis and evaluation of anemia in CKD. Kidney Int Suppl. (2011) 2012;2:288–291.
   PubMed Web of Science ®Google Scholar
• Kliger AS, Foley RN, Goldfarb DS, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD. Am J Kidney Dis. 2013;62(5):849–859.
   PubMed Web of Science ®Google Scholar
• Foundation NK. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50:471–530.
   PubMed Web of Science ®Google Scholar
• Akizawa T, , Makino H, Matsuo S, et al. Management of anemia in chronic kidney disease patients: baseline findings from chronic kidney disease Japan cohort study. Clin Exp Nephrol. 2011;15(2):248–257.
   PubMed Web of Science ®Google Scholar
• Brown CD, Ghali HS, Zhao Z, et al. Association of reduced red blood cell deformability and diabetic nephropathy. Kidney Int. 2005;67(1):295–300.
   PubMed Web of Science ®Google Scholar
• Sasatomi Y, Ito K, Abe Y, et al. Association of hypoalbuminemia with severe anemia in patients with diabetic nephrosclerosis. Renal Failure. 2012;34(2):189–193.
   PubMed Web of Science ®Google Scholar
• Soliman AT, De Sanctis V, Yassin M, et al. Iron deficiency anemia and glucose metabolism. Acta Bio-Medica: Atenei Parmensis. 2017;88:112–118.
   PubMedGoogle Scholar